COVID-19 Clinical Trial
Official title:
Protocol for the First Cycle of the Collaborative Open Research Initiative Study (CORIS-1): An International Survey of Personnel in Health Professions Schools
The Collaborative Open Research Initiative Study (CORIS) is a groundbreaking international research endeavor aimed at exploring vital topics within the field of health professions education. At its core, CORIS embodies the spirit of inclusivity by opening its doors to contributors from all corners of the globe, putting the power of research into the hands of the global community and fostering an environment of open collaboration and meaningful contribution. We invite anyone and everyone to join as collaborators and suggest questions for inclusion in the survey, ensuring that the research process is enriched by diverse perspectives. As a collaborator, you will not only have the opportunity to actively engage in survey design, question formulation, and the entire research process from start to finish, but also gain the prospect of achieving valuable publications, which may boost your professional career.
Introduction: The Collaborative Open Research Initiative Study (CORIS) embarks on an inclusive and innovative international research endeavor, welcoming contributors from across the globe. CORIS fosters a democratic and collaborative approach, shaping research actively and offering publication opportunities for newcomers in health professions education. We describe CORIS' aims and approach in this study. Methods: CORIS, a cross-sectional, web-based survey, seeks to explore critical topics in the field of health professions education. The target population comprises faculty and staff in accredited, degree-granting medical, dental, nursing, pharmacy, and public health schools at both undergraduate and post-graduate levels across 16 countries (n = 14,400). Collaborators can hail from any part of the world but are required to register at https://forms.gle/ZRiwwv3Vmq3y5dv19. Collaborators not only can actively engage in survey design, question formulation, and the entire research process from start to finish but also have the chance to get publications, which can enhance their professional careers. Importantly, there is no financial cost for collaborators at any stage of the study. Results: The first iteration, CORIS-1, scheduled for 2024, covers themes such as post-COVID-19 patient care, epidemic preparedness, burnout, artificial intelligence, remote learning, conflict's impact on mental health, substance use, and workplace discrimination. Data will be collected on the Chisquares™ survey platform, and results, codebook, questionnaire, and methods report will be publicly accessible. No sensitive data or identifying information will be collected. CORIS-1 fosters diversity by letting contributors suggest survey questions, aiming to provide novel data, identify gaps, and influence health education policies. It provides an opportunity for research newcomers to engage in the research process from start to finish, and to get publications. Contributors must meet ICMJE authorship criteria. Collaborators can also explore the collected data for their independent projects. Conclusion: CORIS redefines research, fostering open collaboration and meaningful contributions. Diverse perspectives and collaborators' contributions are expected to enhance the research process. Graduate students working on theses or dissertations can propose questions in CORIS-1, and early career professionals can also enroll as collaborators to gain a comprehensive understanding of the research process from start to finish. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
| Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
| Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
| Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
| Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
| Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
| Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
| Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
| Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
| Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
| Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
| Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
| Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
| Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
| Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
| Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
| Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
| Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|